Published in Biochem Pharmacol on January 18, 2014
Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease. Nat Rev Neurosci (2014) 2.59
Early changes in CSF sTREM2 in dominantly inherited Alzheimer's disease occur after amyloid deposition and neuronal injury. Sci Transl Med (2016) 1.44
Altered microglial response to Aβ plaques in APPPS1-21 mice heterozygous for TREM2. Mol Neurodegener (2014) 1.36
Microglial pathology. Acta Neuropathol Commun (2014) 1.13
Structural and functional rejuvenation of the aged brain by an approved anti-asthmatic drug. Nat Commun (2015) 1.10
Prion-like transmission of neuronal huntingtin aggregates to phagocytic glia in the Drosophila brain. Nat Commun (2015) 1.03
Microglia across the lifespan: from origin to function in brain development, plasticity and cognition. J Physiol (2016) 1.02
Microglia change from a reactive to an age-like phenotype with the time in culture. Front Cell Neurosci (2014) 0.97
sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers. EMBO Mol Med (2016) 0.97
Implications of glial nitric oxide in neurodegenerative diseases. Front Cell Neurosci (2015) 0.93
Microglial cell dysregulation in brain aging and neurodegeneration. Front Aging Neurosci (2015) 0.92
Forebrain microglia from wild-type but not adult 5xFAD mice prevent amyloid-β plaque formation in organotypic hippocampal slice cultures. Sci Rep (2015) 0.92
Characterizing newly repopulated microglia in the adult mouse: impacts on animal behavior, cell morphology, and neuroinflammation. PLoS One (2015) 0.91
Mesenchymal stem cell-based treatments for stroke, neural trauma, and heat stroke. Brain Behav (2016) 0.89
Closed head injury in an age-related Alzheimer mouse model leads to an altered neuroinflammatory response and persistent cognitive impairment. J Neurosci (2015) 0.87
Estrogens, Neuroinflammation, and Neurodegeneration. Endocr Rev (2016) 0.87
The adaptive immune system restrains Alzheimer's disease pathogenesis by modulating microglial function. Proc Natl Acad Sci U S A (2016) 0.87
Early activation of microglia and astrocytes in mouse models of spinocerebellar ataxia type 1. Neuroscience (2015) 0.86
Microglial internalization and degradation of pathological tau is enhanced by an anti-tau monoclonal antibody. Sci Rep (2015) 0.86
The choreography of neuroinflammation in Huntington's disease. Trends Immunol (2015) 0.85
STIM and ORAI proteins in the nervous system. Channels (Austin) (2015) 0.85
Nuclear receptors in neurodegenerative diseases. Neurobiol Dis (2014) 0.85
Temporal gene profiling of the 5XFAD transgenic mouse model highlights the importance of microglial activation in Alzheimer's disease. Mol Neurodegener (2014) 0.85
Stress Granules Modulate SYK to Cause Microglial Cell Dysfunction in Alzheimer's Disease. EBioMedicine (2015) 0.85
The sleep-wake cycle and Alzheimer's disease: what do we know? Neurodegener Dis Manag (2014) 0.84
Neuroinflammation and J2 prostaglandins: linking impairment of the ubiquitin-proteasome pathway and mitochondria to neurodegeneration. Front Mol Neurosci (2015) 0.84
Aging reduces glial uptake and promotes extracellular accumulation of Aβ from a lentiviral vector. Front Aging Neurosci (2014) 0.84
Target engagement analysis and link to pharmacodynamic endpoint for a novel class of CNS-penetrant and efficacious p38α MAPK inhibitors. J Neuroimmune Pharmacol (2014) 0.84
Central nervous system myeloid cells as drug targets: current status and translational challenges. Nat Rev Drug Discov (2015) 0.83
Attenuation of traumatic brain injury-induced cognitive impairment in mice by targeting increased cytokine levels with a small molecule experimental therapeutic. J Neuroinflammation (2015) 0.83
Disease-related microglia heterogeneity in the hippocampus of Alzheimer's disease, dementia with Lewy bodies, and hippocampal sclerosis of aging. Acta Neuropathol Commun (2015) 0.83
Common mechanisms in neurodegeneration and neuroinflammation: a BrainNet Europe gene expression microarray study. J Neural Transm (Vienna) (2014) 0.82
A comprehensive multiomics approach toward understanding the relationship between aging and dementia. Aging (Albany NY) (2015) 0.81
Porphyromonas gingivalis Periodontal Infection and Its Putative Links with Alzheimer's Disease. Mediators Inflamm (2015) 0.81
Association of CD33 polymorphism rs3865444 with Alzheimer's disease pathology and CD33 expression in human cerebral cortex. Neurobiol Aging (2014) 0.80
Young microglia restore amyloid plaque clearance of aged microglia. EMBO J (2016) 0.80
Microglia Priming with Aging and Stress. Neuropsychopharmacology (2016) 0.80
Microglial K(+) channel expression in young adult and aged mice. Glia (2014) 0.80
Ageing, neurodegeneration and brain rejuvenation. Nature (2016) 0.80
Toward more predictive genetic mouse models of Alzheimer's disease. Brain Res Bull (2015) 0.79
Expression of gp91phox and p22phox, catalytic subunits of NADPH oxidase, on microglia in Nasu-Hakola disease brains. Intractable Rare Dis Res (2016) 0.79
Alzheimer's Disease: Mechanism and Approach to Cell Therapy. Int J Mol Sci (2015) 0.79
Spermidine promotes retinal ganglion cell survival and optic nerve regeneration in adult mice following optic nerve injury. Cell Death Dis (2015) 0.79
Microglial Priming and Alzheimer's Disease: A Possible Role for (Early) Immune Challenges and Epigenetics? Front Hum Neurosci (2016) 0.79
Clearance of cerebral Aβ in Alzheimer's disease: reassessing the role of microglia and monocytes. Cell Mol Life Sci (2017) 0.79
Major Shifts in Glial Regional Identity Are a Transcriptional Hallmark of Human Brain Aging. Cell Rep (2017) 0.78
Colocalization of cerebral iron with Amyloid beta in Mild Cognitive Impairment. Sci Rep (2016) 0.78
Microglial Kv1.3 Channels and P2Y12 Receptors Differentially Regulate Cytokine and Chemokine Release from Brain Slices of Young Adult and Aged Mice. PLoS One (2015) 0.78
Amphetamine- and methamphetamine-induced hyperthermia: Implications of the effects produced in brain vasculature and peripheral organs to forebrain neurotoxicity. Temperature (Austin) (2014) 0.78
The sequenced rat brain transcriptome--its use in identifying networks predisposing alcohol consumption. FEBS J (2015) 0.78
Induced pluripotent stem cells as a discovery tool for Alzheimer׳s disease. Brain Res (2015) 0.78
Microglia communication: Parallels between aging and Alzheimer's disease. Clin Exp Neuroimmunol (2016) 0.78
Red peppers with moderate and severe pungency prevent the memory deficit and hepatic insulin resistance in diabetic rats with Alzheimer's disease. Nutr Metab (Lond) (2015) 0.78
Opposing roles of the triggering receptor expressed on myeloid cells 2 and triggering receptor expressed on myeloid cells-like transcript 2 in microglia activation. Neurobiol Aging (2016) 0.77
The Enemy within: Innate Surveillance-Mediated Cell Death, the Common Mechanism of Neurodegenerative Disease. Front Neurosci (2016) 0.77
The evolving biology of microglia in Alzheimer's disease. Neurotherapeutics (2015) 0.77
Therapeutic potential of mGluR5 targeting in Alzheimer's disease. Front Neurosci (2015) 0.77
Expression of suppressor of cytokine signaling genes in human elderly and Alzheimer's disease brains and human microglia. Neuroscience (2014) 0.76
NADPH oxidase (NOX2) activity is a modifier of survival in ALS. J Neurol (2014) 0.76
Neuroimmune and Neuropathic Responses of Spinal Cord and Dorsal Root Ganglia in Middle Age. PLoS One (2015) 0.76
Distinct inflammatory phenotypes of microglia and monocyte-derived macrophages in Alzheimer's disease models: effects of aging and amyloid pathology. Aging Cell (2016) 0.76
Nutrition and AGE-ing: Focusing on Alzheimer's Disease. Oxid Med Cell Longev (2017) 0.76
A novel synthetic compound MCAP suppresses LPS-induced murine microglial activation in vitro via inhibiting NF-kB and p38 MAPK pathways. Acta Pharmacol Sin (2016) 0.76
Delayed glial clearance of degenerating axons in aged Drosophila is due to reduced PI3K/Draper activity. Nat Commun (2016) 0.76
Chronic adiponectin deficiency leads to Alzheimer's disease-like cognitive impairments and pathologies through AMPK inactivation and cerebral insulin resistance in aged mice. Mol Neurodegener (2016) 0.76
Transcriptomic evidence of a para-inflammatory state in the middle aged lumbar spinal cord. Immun Ageing (2017) 0.75
Silver nanoparticles reduce brain inflammation and related neurotoxicity through induction of H2S-synthesizing enzymes. Sci Rep (2017) 0.75
Magnetic Resonance Spectroscopy discriminates the response to microglial stimulation of wild type and Alzheimer's disease models. Sci Rep (2016) 0.75
The effects of HIV and aging on subcortical shape alterations: A 3D morphometric study. Hum Brain Mapp (2016) 0.75
The Lipoxygenases: Their Regulation and Implication in Alzheimer's Disease. Neurochem Res (2015) 0.75
Autophagy resolves early retinal inflammation in Igf1-deficient mice. Dis Model Mech (2016) 0.75
Microglia-Synapse Pathways: Promising Therapeutic Strategy for Alzheimer's Disease. Biomed Res Int (2017) 0.75
Age-Related Decline in the Variation of Dynamic Functional Connectivity: A Resting State Analysis. Front Aging Neurosci (2017) 0.75
Temporal Tracking of Microglia Activation in Neurodegeneration at Single-Cell Resolution. Cell Rep (2017) 0.75
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet (2009) 14.86
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science (2005) 14.43
The hallmarks of aging. Cell (2013) 14.29
Alternative activation of macrophages: mechanism and functions. Immunity (2010) 12.43
ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci (2005) 11.55
TREM2 variants in Alzheimer's disease. N Engl J Med (2012) 11.35
Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci (2007) 11.11
Variant of TREM2 associated with the risk of Alzheimer's disease. N Engl J Med (2012) 10.16
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet (2011) 9.23
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature (2011) 8.45
Local self-renewal can sustain CNS microglia maintenance and function throughout adult life. Nat Neurosci (2007) 7.42
Synaptic pruning by microglia is necessary for normal brain development. Science (2011) 7.35
RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature (1996) 7.04
Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease. Nature (2008) 6.89
The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature (2011) 6.71
Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat Med (2007) 5.87
Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron (2012) 5.84
Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci U S A (1997) 5.66
Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev (2006) 5.61
Gene-expression profile of the ageing brain in mice. Nat Genet (2000) 5.46
Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. J Neurosci (2009) 4.83
Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE. Am J Hum Genet (2008) 4.66
Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease. Cell (2013) 4.45
Microglia shape adult hippocampal neurogenesis through apoptosis-coupled phagocytosis. Cell Stem Cell (2010) 4.30
Systemic infections and inflammation affect chronic neurodegeneration. Nat Rev Immunol (2007) 4.13
Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology. EMBO Rep (2006) 4.06
Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils. Nature (1996) 3.92
Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice. J Neurosci (2008) 3.90
Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation. J Biol Chem (1998) 3.77
NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice. Nature (2012) 3.67
Microglial interactions with synapses are modulated by visual experience. PLoS Biol (2010) 3.59
Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J Neuroimmunol (1989) 3.58
Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta. Neuron (2013) 3.43
Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. Neurosci Lett (1987) 3.13
An English translation of Alzheimer's 1907 paper, "Uber eine eigenartige Erkankung der Hirnrinde". Clin Anat (1995) 3.07
Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention. Dialogues Clin Neurosci (2009) 2.86
Formation and maintenance of Alzheimer's disease beta-amyloid plaques in the absence of microglia. Nat Neurosci (2009) 2.85
Turnover of resident microglia in the normal adult mouse brain. Neuroscience (1992) 2.73
The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex. Biochem J (1993) 2.66
CD36 mediates the innate host response to beta-amyloid. J Exp Med (2003) 2.65
Toll-like receptor 4 stimulation with the detoxified ligand monophosphoryl lipid A improves Alzheimer's disease-related pathology. Proc Natl Acad Sci U S A (2013) 2.45
Inflammation, microglia, and Alzheimer's disease. Neurobiol Dis (2009) 2.44
Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1beta and anti-inflammatory IL-10 cytokines. Brain Behav Immun (2008) 2.37
A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia. J Neurochem (2009) 2.37
Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature. Cold Spring Harb Perspect Med (2012) 2.36
Microglia derived from aging mice exhibit an altered inflammatory profile. Glia (2007) 2.29
Expression of immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer's disease. Neurobiol Aging (1988) 2.24
Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD. J Neuroinflammation (2006) 2.23
Beyond stem cells: self-renewal of differentiated macrophages. Science (2013) 2.23
Microglia mediate the clearance of soluble Abeta through fluid phase macropinocytosis. J Neurosci (2009) 2.20
mRNA up-regulation of MHC II and pivotal pro-inflammatory genes in normal brain aging. Neurobiol Aging (2006) 2.06
Aging as an event of proteostasis collapse. Cold Spring Harb Perspect Biol (2011) 2.06
Increased interleukin-6 expression by microglia from brain of aged mice. J Neuroimmunol (1999) 2.01
Inflammatory response in the hippocampus of PS1M146L/APP751SL mouse model of Alzheimer's disease: age-dependent switch in the microglial phenotype from alternative to classic. J Neurosci (2008) 1.98
TREM2 is upregulated in amyloid plaque-associated microglia in aged APP23 transgenic mice. Glia (2008) 1.97
Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism. Exp Neurol (2001) 1.89
LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide. Brain (2005) 1.81
Microglia and Alzheimer's disease pathogenesis. J Neurosci Res (2004) 1.81
Amyloid-associated neuron loss and gliogenesis in the neocortex of amyloid precursor protein transgenic mice. J Neurosci (2002) 1.72
Fractalkine and CX 3 CR1 regulate hippocampal neurogenesis in adult and aged rats. Neurobiol Aging (2009) 1.72
Distribution of clusterin in Alzheimer brain tissue. Brain Res (1992) 1.67
Microglial cell population dynamics in the injured adult central nervous system. Brain Res Brain Res Rev (2005) 1.67
The sickness behaviour and CNS inflammatory mediator profile induced by systemic challenge of mice with synthetic double-stranded RNA (poly I:C). Brain Behav Immun (2007) 1.65
Deciphering the mechanism underlying late-onset Alzheimer disease. Nat Rev Neurol (2012) 1.64
Microglia in the aging brain. J Neuropathol Exp Neurol (2006) 1.60
Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study. J Neuroinflammation (2012) 1.57
Variant TREM2 as risk factor for Alzheimer's disease. N Engl J Med (2012) 1.57
The microglial phagocytic role with specific plaque types in the Alzheimer disease brain. Neurobiol Aging (2004) 1.56
Microglial expression of MHC class II increases in normal aging of nonhuman primates. Neurobiol Aging (1998) 1.54
Peripheral clearance of amyloid beta peptide by complement C3-dependent adherence to erythrocytes. Neurobiol Aging (2005) 1.51
Age-related alterations in the dynamic behavior of microglia. Aging Cell (2010) 1.49
Insights into TREM2 biology by network analysis of human brain gene expression data. Neurobiol Aging (2013) 1.49
Functional impairment of microglia coincides with Beta-amyloid deposition in mice with Alzheimer-like pathology. PLoS One (2013) 1.48
Microglial chemotaxis, activation, and phagocytosis of amyloid beta-peptide as linked phenomena in Alzheimer's disease. Neurochem Int (2001) 1.47
Ex vivo cultures of microglia from young and aged rodent brain reveal age-related changes in microglial function. Neurobiol Aging (2010) 1.45
Contribution of systemic inflammation to chronic neurodegeneration. Acta Neuropathol (2010) 1.45
Rapid microglial response around amyloid pathology after systemic anti-Abeta antibody administration in PDAPP mice. J Neurosci (2008) 1.43
Protracted downregulation of CX3CR1 on microglia of aged mice after lipopolysaccharide challenge. Brain Behav Immun (2010) 1.43
Aβ-degrading enzymes: potential for treatment of Alzheimer disease. J Neuropathol Exp Neurol (2011) 1.42
Neuroglial cells in the cerebral cortex of rats from young adulthood to old age: an electron microscope study. J Neurocytol (1974) 1.41
Traumatic brain injury in aged animals increases lesion size and chronically alters microglial/macrophage classical and alternative activation states. Neurobiol Aging (2012) 1.41
beta-amyloid activates the O-2 forming NADPH oxidase in microglia, monocytes, and neutrophils. A possible inflammatory mechanism of neuronal damage in Alzheimer's disease. J Biol Chem (1999) 1.40
Stereological analysis of astrocyte and microglia in aging mouse hippocampus. Neurobiol Aging (1999) 1.38
Systemic immune challenges trigger and drive Alzheimer-like neuropathology in mice. J Neuroinflammation (2012) 1.36
Evidence that aging and amyloid promote microglial cell senescence. Rejuvenation Res (2007) 1.35
Amyloid beta and amylin fibrils induce increases in proinflammatory cytokine and chemokine production by THP-1 cells and murine microglia. J Neurochem (2000) 1.34
Phagocytic activity of neuronal progenitors regulates adult neurogenesis. Nat Cell Biol (2011) 1.32
Turnover of resident retinal microglia in the normal adult mouse. Glia (2007) 1.31
Microglia during development and aging. Pharmacol Ther (2013) 1.30
SP-40,40 is a constituent of Alzheimer's amyloid. Acta Neuropathol (1992) 1.30
Microglia express distinct M1 and M2 phenotypic markers in the postnatal and adult central nervous system in male and female mice. J Neurosci Res (2013) 1.28
TLR2 is a primary receptor for Alzheimer's amyloid β peptide to trigger neuroinflammatory activation. J Immunol (2011) 1.27
Lipopolysaccharide-induced interleukin (IL)-4 receptor-α expression and corresponding sensitivity to the M2 promoting effects of IL-4 are impaired in microglia of aged mice. Brain Behav Immun (2011) 1.27
CC chemokine receptor 2 deficiency aggravates cognitive impairments and amyloid pathology in a transgenic mouse model of Alzheimer's disease. J Neurosci (2011) 1.27
Toll-like receptors in Alzheimer's disease. Curr Top Microbiol Immunol (2009) 1.27
Effects of aging and sensory loss on glial cells in mouse visual and auditory cortices. Glia (2012) 1.26
Microglial beclin 1 regulates retromer trafficking and phagocytosis and is impaired in Alzheimer's disease. Neuron (2013) 1.26
Aging-dependent changes of microglial cells and their relevance for neurodegenerative disorders. J Neurochem (2009) 1.25